DL33 and M08 are pioneering treatments aimed at and addressing neurological conditions like dementia and autism. They offer new hope for improving quality of life and advancing neurological care. “To make a difference, you must be different.” By leading with cutting-edge science and a global vision,...See more
Headquarters:
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2018 (8 years)
Address:
null
LOW
spending power
